Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial-Reference-Cited by-同舟云学术

Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial

Published:2023-11 Issue:11 Volume:23 Page:1313-1322
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Zhu Feng-Cai,Zhong Guo-Hua,Huang Wei-Jin,Chu Kai,Zhang Li,Bi Zhao-Feng,Zhu Kong-Xin,Chen Qi,Zheng Ting-Quan,Zhang Ming-Lei,Liu Sheng,Xu Jin-Bo,Pan Hong-Xing,Sun Guang,Zheng Feng-Zhu,Zhang Qiu-Fen,Yi Xiu-Mei,Zhuang Si-Jie,Huang Shou-Jie,Pan Hui-Rong,Su Ying-Ying,Wu Ting,Zhang Jun,Xia Ning-Shao

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference21 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study;de Sanjose;Lancet Oncol,2010

3. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine;Garland;J Infect Dis,2009

4. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis;Drolet;Lancet,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control;Viruses;2024-08-25

2. Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study;npj Vaccines;2024-08-13

3. High-risk human papillomavirus genotyping in cervical cancers in Tanzania;Infectious Agents and Cancer;2024-08-05

4. Safety Assessment of Concurrent Vaccination with the HPV Vaccine and the COVID-19 Vaccine in Fujian Province, China: A Retrospective Study;Vaccines;2024-06-18

5. Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses;Viruses;2024-03-08